New light imaging may predict chemo response in breast cancer
NCT ID NCT02510456
First seen Nov 01, 2025 · Last updated May 10, 2026 · Updated 28 times
Summary
This study tested a noninvasive imaging method called DOSI that uses harmless near-infrared light to monitor how breast tumors respond to chemotherapy. Researchers scanned 24 women undergoing treatment to see if changes in oxygen levels in the tumor could predict whether the cancer would fully disappear. The goal is to provide a safe, bedside tool to guide treatment decisions without radiation or contrast dyes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
Conditions
Explore the condition pages connected to this study.